Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1964 1
1969 1
1971 1
1972 1
1977 1
1978 1
1979 1
1982 1
1983 1
1985 2
1986 2
1987 7
1989 2
1990 2
1991 1
1992 1
1993 4
1994 3
1995 10
1996 5
1997 8
1998 9
1999 12
2000 12
2001 10
2002 10
2003 14
2004 14
2005 18
2006 8
2007 23
2008 25
2009 25
2010 36
2011 34
2012 27
2013 28
2014 29
2015 36
2016 49
2017 50
2018 39
2019 44
2020 65
2021 55
2022 55
2023 69
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

766 results

Results by year

Filters applied: . Clear all
Page 1
Muscle Weakness in Adults: Evaluation and Differential Diagnosis.
Larson ST, Wilbur J. Larson ST, et al. Am Fam Physician. 2020 Jan 15;101(2):95-108. Am Fam Physician. 2020. PMID: 31939642 Free article. Review.
Electromyography is indicated when certain diagnoses are being considered, such as amyotrophic lateral sclerosis, myasthenia gravis, neuropathy, and radiculopathy, and may also guide biopsy. ...
Electromyography is indicated when certain diagnoses are being considered, such as amyotrophic lateral sclerosis, myast …
Motor Neuron Disease: Pathophysiology, Diagnosis, and Management.
Foster LA, Salajegheh MK. Foster LA, et al. Am J Med. 2019 Jan;132(1):32-37. doi: 10.1016/j.amjmed.2018.07.012. Epub 2018 Aug 1. Am J Med. 2019. PMID: 30075105 Review.
Patients with motor neuron diseases may present to primary care clinic or may be initially encountered in the inpatient setting. Timely diagnosis of these conditions is a key factor in early intervention and therapy, and accuracy of diagnosis is of extreme importanc …
Patients with motor neuron diseases may present to primary care clinic or may be initially encountered in the inpatient setting. Time …
Primary lateral sclerosis: consensus diagnostic criteria.
Turner MR, Barohn RJ, Corcia P, Fink JK, Harms MB, Kiernan MC, Ravits J, Silani V, Simmons Z, Statland J, van den Berg LH; Delegates of the 2nd International PLS Conference; Mitsumoto H. Turner MR, et al. J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):373-377. doi: 10.1136/jnnp-2019-322541. Epub 2020 Feb 6. J Neurol Neurosurg Psychiatry. 2020. PMID: 32029539 Free PMC article.
Primary lateral sclerosis (PLS) is a neurodegenerative disorder of the adult motor system. ...Differentiation of PLS from upper motor neuron-predominant forms of amyotrophic lateral sclerosis remains a significant challenge in the early symptoma …
Primary lateral sclerosis (PLS) is a neurodegenerative disorder of the adult motor system. ...Differentiation of PLS from uppe …
Care management in amyotrophic lateral sclerosis.
Soriani MH, Desnuelle C. Soriani MH, et al. Rev Neurol (Paris). 2017 May;173(5):288-299. doi: 10.1016/j.neurol.2017.03.031. Epub 2017 Apr 29. Rev Neurol (Paris). 2017. PMID: 28461024 Review.
Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive and fatal neurodegenerative disease characterized by progressive weakness of voluntary muscles of movement as well as those for swallowing, speech and respiration. ...This review summarizes the …
Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive and fatal neurodegenerative disease characterized by …
ESPEN guideline clinical nutrition in neurology.
Burgos R, Bretón I, Cereda E, Desport JC, Dziewas R, Genton L, Gomes F, Jésus P, Leischker A, Muscaritoli M, Poulia KA, Preiser JC, Van der Marck M, Wirth R, Singer P, Bischoff SC. Burgos R, et al. Clin Nutr. 2018 Feb;37(1):354-396. doi: 10.1016/j.clnu.2017.09.003. Epub 2017 Sep 22. Clin Nutr. 2018. PMID: 29274834
The present evidence- and consensus-based guideline addresses clinical questions on best medical nutrition therapy in patients with neurological diseases. Among them, management of oropharyngeal dysphagia plays a pivotal role. The guideline has been written by a multidisci …
The present evidence- and consensus-based guideline addresses clinical questions on best medical nutrition therapy in patients with n …
Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases.
Tao Y, Leng SX, Zhang H. Tao Y, et al. Curr Neuropharmacol. 2022 Nov 15;20(12):2303-2319. doi: 10.2174/1570159X20666220830102628. Curr Neuropharmacol. 2022. PMID: 36043794 Free PMC article. Review.
Finally, it discusses the common adverse effects of ketogenic therapy. Although the complete mechanism of the ketogenic diet in the treatment of neurodegenerative diseases remains to be elucidated, its clinical efficacy has attracted many new followers. The ketogenic diet …
Finally, it discusses the common adverse effects of ketogenic therapy. Although the complete mechanism of the ketogenic diet in the t …
Muscular cramp: causes and management.
Swash M, Czesnik D, de Carvalho M. Swash M, et al. Eur J Neurol. 2019 Feb;26(2):214-221. doi: 10.1111/ene.13799. Epub 2018 Sep 19. Eur J Neurol. 2019. PMID: 30168894 Review.
It is a particular feature of chronic neurogenic disorders, especially amyotrophic lateral sclerosis. A literature review was undertaken to understand the diverse clinical associations of cramp and its neurophysiological basis, taking into account recent deve …
It is a particular feature of chronic neurogenic disorders, especially amyotrophic lateral sclerosis. A literature revi …
Supportive and symptomatic management of amyotrophic lateral sclerosis.
Hobson EV, McDermott CJ. Hobson EV, et al. Nat Rev Neurol. 2016 Sep;12(9):526-38. doi: 10.1038/nrneurol.2016.111. Epub 2016 Aug 12. Nat Rev Neurol. 2016. PMID: 27514291 Free article. Review.
The main aims in the care of individuals with amyotrophic lateral sclerosis (ALS) are to minimize morbidity and maximize quality of life. Although no cure exists for ALS, supportive and symptomatic care provided by a specialist multidisciplinary …
The main aims in the care of individuals with amyotrophic lateral sclerosis (ALS) are to minimize morbidity and …
Antisense Oligonucleotides for the Study and Treatment of ALS.
Boros BD, Schoch KM, Kreple CJ, Miller TM. Boros BD, et al. Neurotherapeutics. 2022 Jul;19(4):1145-1158. doi: 10.1007/s13311-022-01247-2. Epub 2022 Jun 2. Neurotherapeutics. 2022. PMID: 35653060 Free PMC article. Review.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron loss. ...This review discusses the current state of ASO therapies for ALS, outlining their successes from preclinical development to early clinical t …
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron loss. ...This re …
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.
Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, Mioshi E, Roberts-South A, Benatar M, HortobáGyi T, Rosenfeld J, Silani V, Ince PG, Turner MR. Strong MJ, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):153-174. doi: 10.1080/21678421.2016.1267768. Epub 2017 Jan 5. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28054827 Free PMC article. Review.
This article presents the revised consensus criteria for the diagnosis of frontotemporal dysfunction in amyotrophic lateral sclerosis (ALS) based on an international research workshop on frontotemporal dementia (FTD) and ALS held in London, Canada in June 201 …
This article presents the revised consensus criteria for the diagnosis of frontotemporal dysfunction in amyotrophic lateral …
766 results